Search Results - "Ichikawa, Kosuke"

Measurements of Thermodynamic Data of Water in Ca-Bentonite by Relative Humidity Method by Kosuke Ichikawa, Haruo Sato

“…Buffer material (compacted bentonite), one of the engineered barrier elements in the geological disposal of a high-level radioactive waste, develops swelling…”
Get full text

Combination therapy of cisplatin with cilastatin enables an increased dose of cisplatin, enhancing its antitumor effect by suppression of nephrotoxicity by Arita, Masashi, Watanabe, Satoshi, Aoki, Nobumasa, Kuwahara, Shoji, Suzuki, Ryo, Goto, Sawako, Abe, Yuko, Takahashi, Miho, Sato, Miyuki, Hokari, Satoshi, Ohtsubo, Aya, Shoji, Satoshi, Nozaki, Koichiro, Ichikawa, Kosuke, Kondo, Rie, Hayashi, Masachika, Ohshima, Yasuyoshi, Kabasawa, Hideyuki, Hosojima, Michihiro, Koya, Toshiyuki, Saito, Akihiko, Kikuchi, Toshiaki

“…Cisplatin, one of the most active anticancer agents, is widely used in standard chemotherapy for various cancers. Cisplatin is more poorly tolerated than other…”
Get full text

Observational study of rebiopsy in EGFR-TKI-resistant patients with EGFR mutation-positive advanced NSCLC by Koyama, Kenichi, Miura, Satoru, Watanabe, Satoshi, Shoji, Satoshi, Koshio, Jun, Hayashi, Yoshiki, Ishikawa, Daisuke, Sato, Ko, Miyabayashi, Takao, Okajima, Masaaki, Ota, Takeshi, Tanaka, Tomohiro, Matsumoto, Naoya, Kuriyama, Hideyuki, Abe, Tetsuya, Nozaki, Koichiro, Ichikawa, Kosuke, Kondo, Rie, Tanaka, Hiroshi, Kikuchi, Toshiaki

“…The identification of acquired resistance mutations has been essential in non-small-cell lung cancer (NSCLC) patients with epidermal growth factor receptor…”
Get full text

Disseminated Varicella-zoster Virus Infection Causing Fatal Pneumonia in an Immunocompromised Patient with Chronic Interstitial Pneumonia by Ueno, Hiroshi, Hayashi, Masachika, Nagumo, Shun, Ichikawa, Kosuke, Aoki, Nobumasa, Ohshima, Yasuyoshi, Watanabe, Satoshi, Koya, Toshiyuki, Abé, Tatsuya, Ohashi, Riuko, Ajioka, Yoichi, Kikuchi, Toshiaki

“…Viral pneumonia caused by varicella-zoster virus (VZV) infection is a rare but important complication, especially regarding varicella infections. Although…”
Get full text

Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis by Watanabe, Satoshi, Tanaka, Junta, Ota, Takeshi, Kondo, Rie, Tanaka, Hiroshi, Kagamu, Hiroshi, Ichikawa, Kosuke, Koshio, Jun, Baba, Junko, Miyabayashi, Takao, Narita, Ichiei, Yoshizawa, Hirohisa

“…Gefitinib was the first epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) approved for the treatment of advanced non-small cell lung cancer…”
Get full text

Retrospective analysis of antitumor effects and biomarkers for nivolumab in NSCLC patients with EGFR mutations by Sato, Miyuki, Watanabe, Satoshi, Tanaka, Hiroshi, Nozaki, Koichiro, Arita, Masashi, Takahashi, Miho, Shoji, Satoshi, Ichikawa, Kosuke, Kondo, Rie, Aoki, Nobumasa, Hayashi, Masachika, Ohshima, Yasuyoshi, Koya, Toshiyuki, Ohashi, Riuko, Ajioka, Yoichi, Kikuchi, Toshiaki

“…Although the blockade of programmed cell death 1 (PD-1)/PD-ligand (L) 1 has demonstrated promising and durable clinical responses for non-small-cell lung…”
Get full text

Prospective assessment using 18F-FDG PET/CT as a novel predictor for early response to PD-1 blockade in non-small-cell lung cancer by Yamaguchi, Ou, Kaira, Kyoichi, Naruse, Ichiro, Umeda, Yukihiro, Honda, Takeshi, Watanabe, Satoshi, Ichikawa, Kosuke, Tateishi, Kazunari, Kasahara, Norimitsu, Higuchi, Tetsuya, Hashimoto, Kosuke, Shinomiya, Shun, Miura, Yu, Shiono, Ayako, Mouri, Atsuto, Imai, Hisao, Iizuka, Kunihiko, Ishizuka, Tamotsu, Minato, Koichi, Suda, Satoshi, Kagamu, Hiroshi, Mori, Keita, Kuji, Ichiei, Seki, Nobuhiko

“…Anti-programmed death-1 (PD-1) blockade is a standard treatment for advanced non-small-cell lung cancer (NSCLC). However, no appropriate modality exists for…”
Get full text

PD-1 blockade therapy augments the antitumor effects of lymphodepletion and adoptive T cell transfer by Takahashi, Miho, Watanabe, Satoshi, Suzuki, Ryo, Arita, Masashi, Sato, Ko, Sato, Miyuki, Sekiya, Yuki, Abe, Yuko, Fujisaki, Toshiya, Ohtsubo, Aya, Shoji, Satoshi, Nozaki, Koichiro, Ichikawa, Kosuke, Kondo, Rie, Saida, Yu, Hokari, Satoshi, Aoki, Nobumasa, Hayashi, Masachika, Ohshima, Yasuyoshi, Koya, Toshiyuki, Kikuchi, Toshiaki

“…Lymphodepleting cytotoxic regimens enhance the antitumor effects of adoptively transferred effector and naïve T cells. Although the mechanisms of antitumor…”
Get full text

HER3 activation contributes toward the emergence of ALK inhibitor-tolerant cells in ALK-rearranged lung cancer with mesenchymal features by Tanimura, Keiko, Yamada, Tadaaki, Okada, Koutaroh, Nakai, Kunihiro, Horinaka, Mano, Katayama, Yuki, Morimoto, Kenji, Ogura, Yuri, Takeda, Takayuki, Shiotsu, Shinsuke, Ichikawa, Kosuke, Watanabe, Satoshi, Morimoto, Yoshie, Iwasaku, Masahiro, Kaneko, Yoshiko, Uchino, Junji, Taniguchi, Hirokazu, Yoneda, Kazue, Matoba, Satoaki, Sakai, Toshiyuki, Uehara, Hisanori, Yano, Seiji, Kusaba, Tetsuro, Katayama, Ryohei, Takayama, Koichi

“…Anaplastic lymphoma kinase-tyrosine kinase inhibitors (ALK-TKIs) have shown dramatic efficacy in patients with ALK-rearranged lung cancer; however, complete…”
Get full text

The Prognostic Significance of the Continuous Administration of Anti-PD-1 Antibody via Continuation or Rechallenge After the Occurrence of Immune-Related Adverse Events by Fujisaki, Toshiya, Watanabe, Satoshi, Ota, Takeshi, Kushiro, Kohei, Sato, Yusuke, Takahashi, Miho, Ohtsubo, Aya, Shoji, Satoshi, Nozaki, Koichiro, Ichikawa, Kosuke, Hokari, Satoshi, Kondo, Rie, Miyabayashi, Takao, Abe, Tetsuya, Miura, Satoru, Tanaka, Hiroshi, Okajima, Masaaki, Terada, Masaki, Matsumoto, Naoya, Ishida, Takashi, Iwashima, Akira, Sato, Kazuhiro, Yoshizawa, Hirohisa, Aoki, Nobumasa, Hayashi, Masachika, Ohshima, Yasuyoshi, Koya, Toshiyuki, Kikuchi, Toshiaki

“…Although immune checkpoint inhibitors (ICIs) have been shown to improve overall survival (OS) in advanced non-small-cell lung cancer (NSCLC) patients, ICIs…”
Get full text

Prognostic significance of procalcitonin in small cell lung cancer by Ichikawa, Kosuke, Watanabe, Satoshi, Miura, Satoru, Ohtsubo, Aya, Shoji, Satoshi, Nozaki, Koichiro, Tanaka, Tomohiro, Saida, Yu, Kondo, Rie, Hokari, Satoshi, Aoki, Nobumasa, Ohshima, Yasuyoshi, Koya, Toshiyuki, Kikuchi, Toshiaki

Get full text

Comparative analysis of different response criteria at early phase after PD-1 blockade in non-small lung cancer by Kaira, Kyoichi, Yamaguchi, Ou, Naruse, Ichiro, Umeda, Yukihiro, Honda, Takeshi, Watanabe, Satoshi, Ichikawa, Kosuke, Yanagisawa, Shin, Kasahara, Norimitsu, Higuchi, Tetsuya, Hashimoto, Kosuke, Miura, Yu, Shiono, Ayako, Mouri, Atsuto, Imai, Hisao, Iizuka, Kunihiko, Ishizuka, Tamotsu, Minato, Koichi, Suda, Satoshi, Kagamu, Hiroshi, Mori, Keita, Seki, Nobuhiko, Kuji, Ichiei

“…To compare different response criteria using computed tomography (CT) and positron emission tomography (PET) in measuring response and survival in the early…”
Get full text

Prognostic significance of the radiologic features of pneumonitis induced by anti‐PD‐1 therapy by Watanabe, Satoshi, Ota, Takeshi, Hayashi, Masachika, Ishikawa, Hiroyuki, Otsubo, Aya, Shoji, Satoshi, Nozaki, Koichiro, Ichikawa, Kosuke, Kondo, Rie, Miyabayashi, Takao, Miura, Satoru, Tanaka, Hiroshi, Abe, Tetsuya, Okajima, Masaaki, Terada, Masaki, Ishida, Takashi, Iwashima, Akira, Sato, Kazuhiro, Yoshizawa, Hirohisa, Kikuchi, Toshiaki

“…Background Interstitial lung disease (ILD) induced by anti‐programmed‐cell death‐1 (PD‐1) and anti‐PD‐ligand 1 (PD‐L1) is potentially life‐threatening and is a…”
Get full text

A prospective phase II study of multimodal prophylactic treatment for afatinib-induced adverse events in advanced non-small cell lung cancer (Niigata Lung Cancer Treatment Group 1401) by Okajima, Masaaki, Miura, Satoru, Watanabe, Satoshi, Tanaka, Hiroshi, Ito, Kazuhiko, Ishida, Takashi, Makino, Masato, Iwashima, Akira, Matsumoto, Naoya, Sato, Kazuhiro, Ichikawa, Kosuke, Abe, Tetsuya, Yoshizawa, Hirohisa, Kikuchi, Toshiaki

Get full text

Transfer of in vitro-expanded naïve T cells after lymphodepletion enhances antitumor immunity through the induction of polyclonal antitumor effector T cells by Tanaka, Tomohiro, Watanabe, Satoshi, Takahashi, Miho, Sato, Ko, Saida, Yu, Baba, Junko, Arita, Masashi, Sato, Miyuki, Ohtsubo, Aya, Shoji, Satoshi, Nozaki, Koichiro, Ichikawa, Kosuke, Kondo, Rie, Aoki, Nobumasa, Ohshima, Yasuyoshi, Sakagami, Takuro, Abe, Tetsuya, Moro, Hiroshi, Koya, Toshiyuki, Tanaka, Junta, Kagamu, Hiroshi, Yoshizawa, Hirohisa, Kikuchi, Toshiaki

“…The adoptive transfer of effector T cells combined with lymphodepletion has demonstrated promising antitumor effects in mice and humans, although the…”
Get full text

Efficacy of EGFR‐TKIs with or without upfront brain radiotherapy for EGFR‐mutant NSCLC patients with central nervous system metastases by Saida, Yu, Watanabe, Satoshi, Abe, Tetsuya, Shoji, Satoshi, Nozaki, Koichiro, Ichikawa, Kosuke, Kondo, Rie, Koyama, Kenichi, Miura, Satoru, Tanaka, Hiroshi, Okajima, Masaaki, Terada, Masaki, Ishida, Takashi, Tsukada, Hiroki, Makino, Masato, Iwashima, Akira, Sato, Kazuhiro, Matsumoto, Naoya, Yoshizawa, Hirohisa, Kikuchi, Toshiaki

“…Background Although the clinical efficacy of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKIs) in EGFR‐mutant non‐small cell lung cancer…”
Get full text

Development of a video image‐based QA system for the positional accuracy of dynamic tumor tracking irradiation in the Vero4DRT system by Ebe, Kazuyu, Sugimoto, Satoru, Utsunomiya, Satoru, Kagamu, Hiroshi, Aoyama, Hidefumi, Court, Laurence, Tokuyama, Katsuichi, Baba, Ryuta, Ogihara, Yoshisada, Ichikawa, Kosuke, Toyama, Joji

“…Purpose: To develop and evaluate a new video image‐based QA system, including in‐house software, that can display a tracking state visually and quantify the…”
Get full text

Frequent Germline and Somatic Single Nucleotide Variants in the Promoter Region of the Ribosomal RNA Gene in Japanese Lung Adenocarcinoma Patients by Ohashi, Riuko, Umezu, Hajime, Sato, Ayako, Abé, Tatsuya, Kondo, Shuhei, Daigo, Kenji, Sato, Seijiro, Hara, Norikazu, Miyashita, Akinori, Ikeuchi, Takeshi, Motoyama, Teiichi, Kishi, Masashi, Nagaoka, Tadahiro, Horiuchi, Keiko, Shiga, Atsushi, Okuda, Shujiro, Sekiya, Tomoki, Ohtsubo, Aya, Ichikawa, Kosuke, Kagamu, Hiroshi, Kikuchi, Toshiaki, Watanabe, Satoshi, Tanuma, Jun-Ichi, Schraml, Peter, Hamakubo, Takao, Tsuchida, Masanori, Ajioka, Yoichi

“…Ribosomal RNA (rRNA), the most abundant non-coding RNA species, is a major component of the ribosome. Impaired ribosome biogenesis causes the dysfunction of…”
Get full text

Hypertrophic Pulmonary Osteoarthropathy in Anaplastic Lymphoma Kinase (ALK)-positive Lung Cancer by Komatsu, Masamichi, Yasuo, Masanori, Kobayashi, Nobumitsu, Tateishi, Kazunari, Ushiki, Atsuhito, Urushihata, Kazuhisa, Yamamoto, Hiroshi, Hanaoka, Masayuki, Matoba, Hisanori, Honda, Takayuki, Ichikawa, Kosuke

“…A 49-year-old man was admitted to a hospital with chest pain and polyarthralgia. Chest radiography showed abnormal findings, and chest computed tomography…”
Get full text

Epitope diversification driven by non-tumor epitope-specific Th1 and Th17 mediates potent antitumor reactivity by Ichikawa, Kosuke, Kagamu, Hiroshi, Koyama, Kenichi, Miyabayashi, Takao, Koshio, Jun, Miura, Satoru, Watanabe, Satoshi, Yoshizawa, Hirohisa, Narita, Ichiei

“…Highlights ► Non tumor-specific CD4+ T cells can induce tumor antigen presentation by DC. ► Th1 and Th17, but not Th2 facilitated diverse tumor antigen…”
Get full text